S100A6 and liver dysplastic nodule: Of 10,393 patients with DN enrolled in five studies [599 in Parving et al. (2008); 26 in Persson et al. (2009); 8,561 in the ALTITUDE study (Parving et al., 2012); 64 in Abe et al. (2012); 1,143 in the VIvID study (Bakris et al., 2013)], 370 (3.6%) patients had PRA measured (Persson et al., 2009, 2012a; Abe et al., 2012).